Blar i Department of Clinical Science på tidsskrift "Journal of Hematology & Oncology"
Viser treff 1-1 av 1
-
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
(Journal article; Peer reviewed, 2021)Background Moxetumomab pasudotox is a recombinant CD22-targeting immunotoxin. Here, we present the long-term follow-up analysis of the pivotal, multicenter, open-label trial (NCT01829711) of moxetumomab pasudotox in ...